US Enzymes Market
US demand to grow 6% annually through 2012
US demand for enzymes will rise nearly six percent per year to $2.5 billion in 2012. Advances will be led by continued rapid expansion in the fuel ethanol enzyme market, as well as strong growth in the large pharmaceutical and smaller biocatalyst and pulp and paper markets. Healthy gains will also be realized in diagnostics, research and biotechnology, and cosmetics and toiletries, although this will be offset somewhat by maturity in food and beverages, animal feed and cleaning products applications.
Growth in the US enzyme industry will be dominated by the rapid expansion of the fuel ethanol industry, as ethanol producers strive to meet the country’s renewable fuel needs specified in the Energy Independence and Security Act of 2007. Even as the country reaches a practical limit on how much corn it can convert into ethanol, the rise of second generation, cellulosic biomass ethanol production will continue to drive rapid enzyme demand growth over the longer term.
Pharmaceuticals will remain dominant market
Pharmaceuticals, which will remain the largest enzyme market going forward, will also achieve above average growth. Advances will stem from continuing strong demand for neuromodulators and orphan drug enzymes for treating lysosomal storage disorders. Fast expansion in smaller pharmaceutical applications such as cancer treatment and wound debridement will also support gains.
Please Note: Freedonia requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
RELATED REPORTS
IntroductionThe Comparator Tool builds from the PharmaVitae profiles of the 50 leading pharma companies. Updated monthly, the tool allows you to compare the 50 players by current and forecast sales to 2012.Reasons to Purchase*Compare players by US or global forecast therapy area sales and portfolio ...
Industries : Pharmaceutical
Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory a ...
Industries : Pharmaceutical
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in theCN ...
Industries : Pharmaceutical
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the major current business issues and events, including R&D news, licensing deals, alliances and joint ventu ...
Industries : Pharmaceutical
Datamonitor's MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory an ...
Industries : Pharmaceutical
India, a US$ 8.2 Billion pharmaceutical market, represents one of the most emerging pharmaceutical markets in the world. According to the RNCOS latest report “Booming Pharma Sector in India”, in near future, the potential and opportunities within this market will increase by several folds. The m ...
Industries : Pharmaceutical
Visiongain have the pleasure of announcing the latest edition of their industry leading report - The World OTC Pharmaceutical Market, 2008-2023. This edition updates the world OTC market at present and predicts its sales revenues and trends from 2008-2023, including drivers and restraints on the ma ...
Industries : Pharmaceutical
The major problem facing the Wholesale & Distribution industry is its low profit margin which is in the region of only 1-2%. However, this market is entering into a crucial period with many key products losing patent protection, facing heavy generic competition. As generics are priced lower than ...
Industries : Pharmaceutical
Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treat ...
Industries : Pharmaceutical
The aging of the population, namely the baby boomer demographic segment is driving the market for facial rejuvenation products. The size and wealth of this aging segment and its overwhelming desire to retain a youthful appearance are driving growth for aesthetic procedures. Worldwide, billions of do ...
Industries : Pharmaceutical, Cosmetic and Toiletry
Related industries
reportlinker.com © Copyright 2009. All rights reserved